GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Brooks Laboratories Ltd (BOM:533543) » Definitions » Total Assets

Brooks Laboratories (BOM:533543) Total Assets : ₹911.2 Mil (As of Sep. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Brooks Laboratories Total Assets?

Brooks Laboratories's Total Assets for the quarter that ended in Sep. 2024 was ₹911.2 Mil.

During the past 12 months, Brooks Laboratories's average Total Assets Growth Rate was -15.40% per year. During the past 3 years, the average Total Assets Growth Rate was -17.60% per year. During the past 5 years, the average Total Assets Growth Rate was -10.60% per year. During the past 10 years, the average Total Assets Growth Rate was -0.20% per year.

During the past 13 years, Brooks Laboratories's highest 3-Year average Total Assets Growth Rate was 43.60%. The lowest was -17.60%. And the median was 10.65%.

Total Assets is connected with ROA %. Brooks Laboratories's annualized ROA % for the quarter that ended in Sep. 2024 was -17.40%. Total Assets is also linked to Revenue through Asset Turnover. Brooks Laboratories's Asset Turnover for the quarter that ended in Sep. 2024 was 0.23.


Brooks Laboratories Total Assets Historical Data

The historical data trend for Brooks Laboratories's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brooks Laboratories Total Assets Chart

Brooks Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,578.64 1,620.77 1,959.11 1,095.97 904.45

Brooks Laboratories Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,059.92 - 904.45 - 911.24

Brooks Laboratories Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Brooks Laboratories's Total Assets for the fiscal year that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (A: Mar. 2024 )+Total Liabilities (A: Mar. 2024 )
=655.853+248.601
=904.5

Brooks Laboratories's Total Assets for the quarter that ended in Sep. 2024 is calculated as

Total Assets=Total Equity (Q: Sep. 2024 )+Total Liabilities (Q: Sep. 2024 )
=592.086+319.156
=911.2

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Brooks Laboratories  (BOM:533543) Total Assets Explanation

Total Assets is connected with ROA %.

Brooks Laboratories's annualized ROA % for the quarter that ended in Sep. 2024 is

ROA %=Net Income (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=-158.536/( (0+911.242)/ 1 )
=-158.536/911.242
=-17.40 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Brooks Laboratories's Asset Turnover for the quarter that ended in Sep. 2024 is

Asset Turnover
=Revenue (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=207.921/( (0+911.242)/ 1 )
=207.921/911.242
=0.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Brooks Laboratories Total Assets Related Terms

Thank you for viewing the detailed overview of Brooks Laboratories's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Brooks Laboratories Business Description

Traded in Other Exchanges
Address
Off. Andheri Kurla Road, 201, The Summit Business Park, Behind Guru Nanak Petrol Pump, Andheri (East), Mumbai, MH, IND, 400 093
Brooks Laboratories Ltd is an Indian company operating in the healthcare sector. The company is engaged in the formulation, development, production, and export of drugs and pharmaceuticals. The company operates under one segment: Pharmaceutical products including ingredients and intermediaries. It manufactures drugs in a variety of forms, including tablets, dry syrup, injections, liquid injections, dry powder injections, eye drops, and ear drops. Its products include carbapenem and penicillins.

Brooks Laboratories Headlines

No Headlines